XML 73 R65.htm IDEA: XBRL DOCUMENT
v3.25.3

Key Management Personnel Disclosures (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2025
Statements [Line Items] |
Summary of Directors and Key Management Personnel Compensation | (a) Directors and key management personnel compensation
|  | Consolidated |
| June 30, 2025 A$ |  |  | June 30, 2024 A$ |  |  | June 30, 2023 A$ |
Short-term employee benefits |  |  | 3,401,189 |  |  |  | 2,656,821 |  |  |  | 1,471,671 |
Long-term employee benefits |  |  | 17,028 |  |  |  | 3,861 |  |  |  | 11,967 |
Post-employment benefits |  |  | 81,223 |  |  |  | 66,891 |  |  |  | 54,548 |
Share-based payments |  |  | 905,305 |  |  |  | 1,259,571 |  |  |  | 1,380,074 |
|  |  | 4,404,745 |  |  |  | 3,987,144 |  |  |  | 2,918,260 |
Ordinary Shares [member] |
Statements [Line Items] |
Summaries of All STI and LTI Performance Rights Granted Under the EIP | The numbers of shares in the company held during the financial year by each director of and other key management personnel of the Group, including their personally related parties, are set out below. There were no shares granted during the reporting period as compensation.
June 30, 2025 |  | Balance at start of the fiscal year |  |  | Received during the fiscal year on exercise of performance rights |  |  | Received during the fiscal year on the exercise of options |  |  | Other changes during the fiscal year # |  |  | Balance at end of the fiscal year |
Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 1,113,207 |  |  |  | 304,770 |  |  |  | — |  |  |  | — |  |  |  | 1,417,977 |
Mr Pete Meyers |  |  | 3,274,395 |  |  |  | 388,889 |  |  |  | — |  |  |  | — |  |  |  | 3,663,284 |
Mr Marc Voigt |  |  | 11,247,445 |  |  |  | 2,400,000 |  |  |  | — |  |  |  | 29,500 |  |  |  | 13,676,945 |
Dr Frédéric Triebel |  |  | 8,653,764 |  |  |  | 1,800,000 |  |  |  | — |  |  |  | — |  |  |  | 10,453,764 |
Ms A Anderson |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Dr F Vogl |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Mr Christian Mueller |  |  | 2,840,715 | * |  |  | 466,667 | * |  |  | — |  |  |  | — |  |  |  | 3,307,382 |
Ms Lis Boyce |  |  | — |  |  |  | 256,621 |  |  |  | — |  |  |  | — |  |  |  | 256,621 |
Ms Deanne Miller |  |  | 2,067,305 |  |  |  | 1,200,000 |  |  |  | — |  |  |  | (800,000 | ) |  |  | 2,467,305 |
Total ordinary shares |  |  | 29,196,831 |  |  |  | 6,816,947 |  |  |  | — |  |  |  | (770,500 | ) |  |  | 35,243,278 |
ADSs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mr Marc Voigt |  |  | 45 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 45 |
Dr Frédéric Triebel |  |  | 17,061 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,061 |
Total ADSs |  |  | 17,106 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,106 |
# | Other changes during the year includes on market acquisitions and/or disposals.
* | Shares held before being appointed as key management personnel.
June 30, 2024 |  | Balance at start of the fiscal year |  |  | Received during the fiscal year on exercise of performance rights |  |  | Received during the fiscal year on the exercise of options |  |  | Other changes during the fiscal year # |  |  | Balance at end of the fiscal year |
Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 1,113,207 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,113,207 |
Mr Pete Meyers |  |  | 2,774,395 |  |  |  | 500,000 |  |  |  | — |  |  |  | — |  |  |  | 3,274,395 |
Mr Marc Voigt |  |  | 11,247,445 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 11,247,445 |
Dr Frédéric Triebel |  |  | 8,653,764 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 8,653,764 |
Ms A Anderson |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Dr F Vogl |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Lis Boyce |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Deanne Miller |  |  | 3,267,305 |  |  |  | — |  |  |  | — |  |  |  | (1,200,000 | ) |  |  | 2,067,305 |
Total ordinary shares |  |  | 27,056,116 |  |  |  | 500,000 |  |  |  | — |  |  |  | (1,200,000 | ) |  |  | 26,356,116 |
ADSs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mr Marc Voigt |  |  | 45 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 45 |
Dr Frédéric Triebel |  |  | 17,061 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,061 |
Total ADSs |  |  | 17,106 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,106 |
# | Other changes during the year includes on market acquisitions and/or disposals
June 30, 2023 |  | Balance at start of the fiscal year |  |  | Received during the fiscal year on exercise of performance rights |  |  | Received during the fiscal year on the exercise of options |  |  | Other changes during the fiscal year# |  |  | Balance at end of the fiscal year |
Ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 1,000,000 |  |  |  | 113,207 |  |  |  | — |  |  |  | — |  |  |  | 1,113,207 |
Mr Pete Meyers |  |  | 2,274,395 |  |  |  | 500,000 |  |  |  | — |  |  |  | — |  |  |  | 2,774,395 |
Mr Marc Voigt |  |  | 8,847,445 |  |  |  | 2,400,000 |  |  |  | — |  |  |  | — |  |  |  | 11,247,445 |
Dr Frédéric Triebel |  |  | 7,753,764 |  |  |  | 900,000 |  |  |  | — |  |  |  | — |  |  |  | 8,653,764 |
Ms Lucy Turnbull |  |  | 3,284,126 |  |  |  | 92,966 |  |  |  | — |  |  |  | (3,377,092 | )* |  |  | — |
Ms Lis Boyce |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Deanne Miller |  |  | 2,767,305 |  |  |  | 600,000 |  |  |  | — |  |  |  | (100,000 | )# |  |  | 3,267,305 |
Total ordinary shares |  |  | 25,927,035 |  |  |  | 4,606,173 |  |  |  | — |  |  |  | (3,477,092 | ) |  |  | 27,056,116 |
ADSs |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Mr Marc Voigt |  |  | 45 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 45 |
Dr Frédéric Triebel |  |  | 17,061 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,061 |
Total ADSs |  |  | 17,106 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 17,106 |
# | Other changes during the year includes on market acquisitions and/or disposals
* | This change during the year represents derecognition due to the cessation of the director’s position
Performance rights [member] |
Statements [Line Items] |
Summaries of All STI and LTI Performance Rights Granted Under the EIP | The number of performance rights over ordinary shares in the parent entity held during the year by each director and other members of key management personnel of the consolidated entity, including their personally related parties, is set out below.
June 30, 2025 |  | Balance at start of the fiscal year |  |  | Granted |  |  | Exercised |  |  | Other Changes |  |  | Balance at end of the fiscal year |  |  | Vested and exercisable |  |  | Unvested |
Performance rights over ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 404,770 |  |  |  | — |  |  |  | (304,770 | ) |  |  | — |  |  |  | 100,000 |  |  |  | — |  |  |  | 100,000 |
Mr Pete Meyers |  |  | 1,166,667 |  |  |  | — |  |  |  | (388,889 | ) |  |  | — |  |  |  | 777,778 |  |  |  | — |  |  |  | 777,778 |
Mr Marc Voigt |  |  | 3,600,000 |  |  |  | 3,600,000 |  |  |  | (2,400,000 | ) |  |  | — |  |  |  | 4,800,000 |  |  |  | — |  |  |  | 4,800,000 |
Dr Frédéric Triebel |  |  | 2,700,000 |  |  |  | 2,700,000 |  |  |  | (1,800,000 | ) |  |  | — |  |  |  | 3,600,000 |  |  |  | — |  |  |  | 3,600,000 |
Ms Anne Anderson |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Lis Boyce |  |  | 589,955 |  |  |  | — |  |  |  | (256,621 | ) |  |  | — |  |  |  | 333,334 |  |  |  | — |  |  |  | 333,334 |
Ms Deanne Miller |  |  | 1,800,000 |  |  |  | 1,800,000 |  |  |  | (1,200,000 | ) |  |  | — |  |  |  | 2,400,000 |  |  |  | — |  |  |  | 2,400,000 |
Mr Christian Mueller |  |  | 933,333 | * |  |  | 1,400,000 | * |  |  | (466,667 | )* |  |  | — |  |  |  | 1,866,666 |  |  |  | — |  |  |  | 1,866,666 |
Dr Florian Vogl |  |  | 1,343,856 |  |  |  | — |  |  |  | — |  |  |  | (1,343,856 | ) |  |  | — |  |  |  | — |  |  |  | — |
|  |  | 12,538,581 |  |  |  | 9,500,000 |  |  |  | (6,816,947 | ) |  |  | (1,343,856 | ) |  |  | 13,877,778 |  |  |  | — |  |  |  | 13,877,778 |
* | Performance rights held before being appointed as key management personnel
June 30, 2024 |  | Balance at start of the fiscal year |  |  | Granted |  |  | Exercised |  |  | Other Changes |  |  | Balance at end of the fiscal year |  |  | Vested and exercisable |  |  | Unvested |
Performance rights over ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 226,414 |  |  |  | 178,356 |  |  |  | — |  |  |  | — |  |  |  | 404,770 |  |  |  | 141,563 |  |  |  | 263,207 |
Mr Pete Meyers |  |  | 1,666,667 |  |  |  | — |  |  |  | (500,000 | ) |  |  | — |  |  |  | 1,166,667 |  |  |  | — |  |  |  | 1,166,667 |
Mr Marc Voigt |  |  | 3,600,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 3,600,000 |  |  |  | 1,200,000 |  |  |  | 2,400,000 |
Dr Frédéric Triebel |  |  | 2,700,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 2,700,000 |  |  |  | 900,000 |  |  |  | 1,800,000 |
Ms Anne Anderson |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Lis Boyce |  |  | — |  |  |  | 589,955 |  |  |  | — |  |  |  | — |  |  |  | 589,955 |  |  |  | 89,954 |  |  |  | 500,001 |
Ms Deanne Miller |  |  | 1,800,000 |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | 1,800,000 |  |  |  | 600,000 |  |  |  | 1,200,000 |
Dr Florian Vogl |  |  | — |  |  |  | 1,343,856 |  |  |  | — |  |  |  | — |  |  |  | 1,343,856 |  |  |  | — |  |  |  | 1,343,856 |
|  |  | 9,993,081 |  |  |  | 2,112,167 |  |  |  | (500,000 | ) |  |  | — |  |  |  | 11,605,248 |  |  |  | 2,931,517 |  |  |  | 8,673,731 |
June 30, 2023 |  | Balance at Start of the fiscal year |  |  | Granted |  |  | Exercised |  |  | Other Changes |  |  | Balance at end of the fiscal year |  |  | Vested and exercisable |  |  | Unvested |
Performance rights over ordinary shares |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Dr Russell Howard |  |  | 339,621 |  |  |  | — |  |  |  | (113,207 | ) |  |  | — |  |  |  | 226,414 |  |  |  | — |  |  |  | 226,414 |
Mr Pete Meyers |  |  | 1,000,000 |  |  |  | 1,166,667 |  |  |  | (500,000 | ) |  |  | — |  |  |  | 1,666,667 |  |  |  | — |  |  |  | 1,666,667 |
Mr Marc Voigt |  |  | 6,000,000 |  |  |  | — |  |  |  | (2,400,000 | ) |  |  | — |  |  |  | 3,600,000 |  |  |  | — |  |  |  | 3,600,000 |
Dr Frédéric Triebel |  |  | 3,600,000 |  |  |  | — |  |  |  | (900,000 | ) |  |  | — |  |  |  | 2,700,000 |  |  |  | — |  |  |  | 2,700,000 |
Ms Lucy Turnbull |  |  | — |  |  |  | 457,832 |  |  |  | (92,966 | ) |  |  | (364,866 | )* |  |  | — |  |  |  | — |  |  |  | — |
Ms Lis Boyce |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Ms Deanne Miller |  |  | 2,400,000 |  |  |  | — |  |  |  | (600,000 | ) |  |  | — |  |  |  | 1,800,000 |  |  |  | — |  |  |  | 1,800,000 |
|  |  | 13,339,621 |  |  |  | 1,624,499 |  |  |  | (4,606,173 | ) |  |  | (364,866 | ) |  |  | 9,993,081 |  |  |  | — |  |  |  | 9,993,081 |
* | The change during the year represents derecognition due to the cessation of the director’s position.

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2025-01-01 -Paragraph 45 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2025-en-r&anchor=para_45&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of transactions between the entity and its related parties. [Refer: Total for all related parties [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IAS -Number 24 -IssueDate 2025-01-01 -Paragraph 18 -URI https://taxonomy.ifrs.org/xifrs-link?type=IAS&num=24&code=ifrs-tx-2025-en-r&anchor=para_18&doctype=Standard -URIDate 2025-03-27 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 230 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard -URIDate 2025-03-27 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Note Effective 2027-01-01 -Name IFRS -Number 19 -IssueDate 2025-01-01 -Paragraph 230 -URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=19&code=ifrs-tx-2025-en-r&anchor=para_230&doctype=Standard -URIDate 2025-03-27 + Details
Name: | ifrs-full_DisclosureOfTransactionsBetweenRelatedPartiesExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | dtr-2022:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | immp_StatementsLineItems
Namespace Prefix: | immp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=ifrs-full_OrdinarySharesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | ifrs-full_ClassesOfShareCapitalAxis=immp_PerformanceRightsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |